TIBIO – Azienda ticinese selezionata tra gli attori chiave nel mercato mondiale dei prodotti chimici basati sulle biotecnologie

A Consulting Company for Scientific...

Helsinn announces publication of new data evaluating impact of NEPA (netupitant/palonosetron) on hospital costs

LUGANO, Switzerland - February 3, 2023 - Helsinn Group...

Helsinn and Immedica enter exclusive partnership for commercialisation of cancer supportive care products in core European markets

LUGANO, Switzerland and STOCKHOLM, Sweden – January 24, 2023...